A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

ClinicalTrials.gov ID: NCT07201922

Public ClinicalTrials.gov record NCT07201922. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 29, 2026, 10:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double Blind, Randomized, Placebo-controlled Exploratory Trial to Investigate the Efficacy and Safety of Nerandomilast Over 24 Months When Administered in Individuals With Interstitial Lung Abnormalities and a Family History of Pulmonary Fibrosis to Reduce the Risk of Worsening (DROP-FPF)

Study identification

NCT ID: NCT07201922
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Boehringer Ingelheim; Industry
Enrollment: 80 participants

Conditions and interventions

Conditions

Interventions

Nerandomilast Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 40 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 9, 2026
Primary completion: May 13, 2029
Completion: May 22, 2029
Last update posted: Apr 27, 2026

2026 – 2029

United States locations

U.S. sites: 13
U.S. states: 13
U.S. cities: 13

Facility	City	State	ZIP	Site status
University of California Los Angeles	Los Angeles	California	90095	Not yet recruiting
University of Colorado Denver	Aurora	Colorado	80045	Not yet recruiting
Clinical Research Specialists LLC - Kissimmee	Kissimmee	Florida	34746	Not yet recruiting
University of Kansas Medical Center	Kansas City	Kansas	66160	Not yet recruiting
Brigham and Women's Hospital	Boston	Massachusetts	02115	Not yet recruiting
University of Michigan	Ann Arbor	Michigan	48109	Not yet recruiting
University of Minnesota	Minneapolis	Minnesota	55455	Not yet recruiting
Weill Cornell Medicine-New York-60569	New York	New York	10021	Not yet recruiting
University of Pennsylvania	Philadelphia	Pennsylvania	19104	Not yet recruiting
Medical University of South Carolina	Charleston	South Carolina	29425	Not yet recruiting
Vanderbilt University Medical Center	Nashville	Tennessee	37204	Not yet recruiting
Baylor College of Medicine	Houston	Texas	77030	Not yet recruiting
Virginia Commonwealth University	Richmond	Virginia	23298	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07201922, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 27, 2026 · Synced Apr 29, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07201922 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →